Oxicodonă Sandoz (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxicodonă Sandoz, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxicodonă Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxicodonă Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxicodonă Sandoz is an opioid analgesic that acts on the central nervous system to relieve pain.

- Acute postoperative pain: provides strong analgesia during the recovery period after surgery. - Cancer‑related pain: helps manage persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: reduces pain intensity when other treatments have failed. - Traumatic injury pain: alleviates pain from severe injuries such as fractures or burns.

Side effects may occur with opioid therapy and should be monitored.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea and vomiting: stimulation of the chemoreceptor trigger zone. - Drowsiness: central nervous system depression. - Dry mouth: decreased salivary secretion. - Light‑headedness: orthostatic hypotension. - Pruritus: histamine release.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Dependence and addiction: potential for misuse and withdrawal. - Seizures: rare neurologic events. - Anaphylaxis: acute allergic reaction. - adrenal insufficiency: rare endocrine disturbance.

When prescribing Oxicodonă Sandoz, clinicians should consider several safety measures.

- Assess pain severity: confirm that opioid therapy is appropriate. - Evaluate respiratory function: monitor for depression, especially after dose changes. - Review patient history: check for substance abuse or dependence risk. - Avoid concurrent CNS depressants: limit use with alcohol, benzodiazepines, or other sedatives. - Educate patients: inform about proper use, storage, and disposal. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxicodonă Sandoz can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent use with other strong opioid agonists: increased risk of respiratory depression. - Benzodiazepines or barbiturates: additive central nervous system depression. - Mono‑Mono‑Mono  

Moderate   - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise oxy‑hydroxy‑oxy‑ - CYP   t   t  . - Anticholinergic agents: may worsen constipation. - Diuret  . - Alcohol: enhances sedative effects and respiratory risk.